- Rank
- 568th of 809
- Companies held
- 1
- Largest holding
- PATH, 100.0% of total
- Latest SEC filing
- Jun 5, 2023
- Listed but not counted
- $325M
What the $132M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| UiPath PATH Class A common stock | Directly | 9,069,430 | $11.23 | $102M | 77.0% | Form 4, Jun 5, 2023 |
| UiPath PATH Class A common stock | Indirectly (see filing footnote) | 2,705,351 | $11.23 | $30.4M | 23.0% | Form 4, Jun 5, 2023 |
Share counts are the amounts Accel London Investors 2016 L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Accel London Investors 2016 L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| UiPath PATH Class A common stock | Accel London V Strategic Partners L.P. Held by an investment fund or partnership | 27,999,995 | $11.23 | $314M | — | Form 4, Jun 5, 2023 |
| UiPath PATH Class A common stock | Accel London V L.P. Held by a company or fund the insider manages | 433,812 | $11.23 | $4.9M | — | Form 4, Jun 5, 2023 |
| UiPath PATH Class A common stock | Accel London Investors 2016 L.P. Held by an investment fund or partnership | 426,502 | $11.23 | $4.8M | — | Form 4, Jun 5, 2023 |
| UiPath PATH Class A common stock | Accel Growth Fund Investors 2016 L.L.C. Held by an investment fund or partnership | 51,609 | $11.23 | $580K | — | Form 4, Jun 5, 2023 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 565 | KLP 2006-N3 Family Trust Insider, Hyatt Hotels | $135M |
| 566 | Charles F. Dolan 2009 Family Trust Fbo Marianne Dolan Weber Insider, MSG Knickerbockers | $135M |
| 567 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner, MBX Biosciences | $134M |
| 568 | Accel London Investors 2016 L.P. 10% owner, UiPath | $132M |
| 569 | CilMar Ventures, LLC Series A 10% owner, Falcon's Beyond Global | $132M |
| 570 | Idea Men, LLC Director, GoodRx Holdings | $130M |
| 571 | Opko Health, Inc. 10% owner, GeneDx Holdings | $130M |
Other UiPath insiders
All PATH insiders- Daniel Dines$1.11BCEO and Chairman. #249 overall
- Philippe Botteri$35.7MDirector. #3277 overall
- Robert Enslin$35.0Mfmr CEO, Director. #1905 overall
- Ted Kummert$32.3MHead of Product & Engineering. #3562 overall
- Carl M. Eschenbach$29.0MDirector. #532 overall
- Ashim Gupta$27.8MCOO. #4018 overall
Questions
How much stock does Accel London Investors 2016 L.P. own?
Accel London Investors 2016 L.P. holds $132,230,791 in listed stock based on SEC filings and current prices, mostly UiPath (PATH). That ranks 568th on the Stock Rich List.
Is this Accel London Investors 2016 L.P.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.